Tap into proven expertise with small patient populations
The Biologics team combines specialty pharmacy operational experience with deep clinical insight into small patient populations, including rare, ultra-rare and orphan diseases, and the reimbursement pathways that support access to care. Our logistical and clinical expertise supports highly personalized treatment journeys spanning metabolic, neuromuscular, immunologic, and nephrotic disease states, among many others, while also coordinating with providers who may be new to the specialty space.
This approach also addresses the social and emotional needs of children, teenagers and caregivers navigating physically, mentally and financially taxing journeys. By tailoring our proven rare-disease methodologies to accommodate patient dynamics, manufacturer priorities and regulatory mandates, the Biologics team serves as a trusted ally to manufacturers introducing new treatment options to vital niche markets.
Rare disease specialty pharmacy highlights
30 +
Years of specialty expertise, including first-in-class launches
25 +
Rare/orphan disease therapies in our inventory
115 +
Limited distribution drugs, including rare/orphan disease therapies
20 +
Years managing Risk Evaluation and Mitigation Strategy (REMS) therapies
8,000 +
Active provider relationships in rare disease
50 +
Robust licensing in all U.S. states and territories
A rare combination: commercial and clinical expertise
For more than 30 years, the Biologics team has partnered with manufacturers to simplify specialty journeys for patients, providers and biopharma companies. With more than two dozen therapies for rare or orphan diseases in our network, along with extensive experience with exclusive and limited distribution drugs, the Biologics team has a history of shared success with our rare disease drug partners.
Just as we educate patients and caregivers about the clinical journey, we also provide guidance to providers who may not work directly within the rare disease space, working with them through the process of prior approvals, clinical considerations and appeals letters as needed. We also maintain strong lines of communication to keep our partners informed throughout these complex courses of treatment.
As a trusted rare disease specialty pharmacy partner, we help biopharma manufacturers make a positive impact on patients and providers by:
Collecting and reporting targeted data to support complex prior authorizations, appeals and adherence
Leveraging deep rare disease relationships to navigate market dynamics
Delivering patient hubs and data services to support rare disease journeys
Providing field sales teams to strengthen provider engagement
Identifying the right channel strategy for each partner
Proactively exploring copay and foundational aid for rare disease patients
Customizing process flows and business rules based on partner needs
Providing a dedicated implementation team, from planning to execution
It’s rare these days to work with a company that is so professional. I was impressed with each and every person I spoke with. From the monthly delivery scheduling people to the nurses that periodically called to the pharmacists and medical counselors. And the delivery of my monthly meds was flawless as well.
From launch through treatment
Our approach to commercialization and clinical support for rare disease journeys is rooted in therapy-specific education and understanding. Our disease- and therapy-aligned teams receive in-depth training on each disease, access pathways and barriers, patient and family considerations, payer appeals and other complexities of rare disease care. This shared knowledge equips our multidisciplinary teams to navigate the many aspects of rare disease therapy efficiently and effectively.
Trusted rare disease capabilities for complex populations
Two dispensing facilities + data redundancy
Questions about rare disease commercialization support?
A Patient-Centric Partnership in Rare Disease Care
Learn more about how McKesson is building an ecosystem that connects biopharma, providers, pharmacies and payers to successfully develop and commercialize medications while maximizing our collective impact on the lives of patients.
High‑touch rare disease clinical support
Personalized clinical management to support access, appeals and adherence.
Supporting oncology patient journeys
Explore Biologics’ oncology capabilities across access, clinical support and commercialization.
Designed for complex patient journeys
Purpose‑built hub programs supporting oncology, rare disease and cell & gene therapy.